was read the article
array:23 [ "pii" => "S0121812318300094" "issn" => "01218123" "doi" => "10.1016/j.rcreu.2018.02.001" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "169" "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Rev Colomb Reumatol. 2018;25:1-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 433 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 294 "PDF" => 138 ] ] "Traduccion" => array:1 [ "en" => array:18 [ "pii" => "S2444440518300190" "issn" => "24444405" "doi" => "10.1016/j.rcreue.2018.05.002" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "169" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Rev Colomb Reumatol. 2018;25:1-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 252 "formatos" => array:3 [ "EPUB" => 28 "HTML" => 145 "PDF" => 79 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Starting biologic therapy in rheumatoid arthritis. A Colombian experience" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "2" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Inicio de la terapia biológica en la artritis reumatoide. Experiencia colombiana" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mario H. Cardiel" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Mario H." "apellidos" => "Cardiel" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0121812318300094" "doi" => "10.1016/j.rcreu.2018.02.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0121812318300094?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444440518300190?idApp=UINPBA00004N" "url" => "/24444405/0000002500000001/v1_201810160636/S2444440518300190/v1_201810160636/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0121812317301305" "issn" => "01218123" "doi" => "10.1016/j.rcreu.2017.11.002" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "163" "copyright" => "Asociación Colombiana de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Colomb Reumatol. 2018;25:3-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 689 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 502 "PDF" => 186 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Investigation</span>" "titulo" => "Time to and factors associated with initiation of biological therapy in patients with rheumatoid arthritis in Colombia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "3" "paginaFinal" => "8" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tiempo y factores asociados con el inicio de terapia biológica con antirreumáticos modificadores de enfermedad en pacientes con Artritis Reumatoide en Colombia" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1393 "Ancho" => 1554 "Tamanyo" => 73038 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Kaplan–Meier estimates of progression percentage of patients by sex to compare time to until the onset of biological disease-modifying antirheumatic drugs (DMARDs) after the beginning of non-biological DMARD therapy in 5 years of follow-up. Colombia 2007–2013.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jorge E. Machado-Alba, Santiago García-Betancur, Luis F. Calvo-Torres, Diego Alejandro Medina-Morales, Alejandra M. Bañol-Giraldo" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Jorge E." "apellidos" => "Machado-Alba" ] 1 => array:2 [ "nombre" => "Santiago" "apellidos" => "García-Betancur" ] 2 => array:2 [ "nombre" => "Luis F." "apellidos" => "Calvo-Torres" ] 3 => array:2 [ "nombre" => "Diego Alejandro" "apellidos" => "Medina-Morales" ] 4 => array:2 [ "nombre" => "Alejandra M." "apellidos" => "Bañol-Giraldo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2444440518300207" "doi" => "10.1016/j.rcreue.2018.05.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444440518300207?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0121812317301305?idApp=UINPBA00004N" "url" => "/01218123/0000002500000001/v1_201803210433/S0121812317301305/v1_201803210433/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S0121812318300124" "issn" => "01218123" "doi" => "10.1016/S0121-8123(18)30012-4" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "80000240" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "edb" "cita" => "Rev Colomb Reumatol. 2018;25:e1-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 308 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 91 "PDF" => 216 ] ] "en" => array:6 [ "idiomaDefecto" => true "titulo" => "Comité Editorial online" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e1" "paginaFinal" => "e3" ] ] "contienePdf" => array:1 [ "en" => true ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0121812318300124?idApp=UINPBA00004N" "url" => "/01218123/0000002500000001/v1_201803210433/S0121812318300124/v1_201803210433/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Starting biologic therapy in rheumatoid arthritis. A Colombian experience" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "2" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Mario H. Cardiel" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Mario H." "apellidos" => "Cardiel" "email" => array:1 [ 0 => "mhcardiel@hotmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Centro de Investigación Clínica de Morelia, Morelia, Mich, Mexico" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Inicio de la terapia biológica en la artritis reumatoide. Experiencia colombiana" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Rheumatoid arthritis (RA) is a fascinating and challenging disease that rheumatologists treat every day. Important therapeutic and conceptual advances have occurred in the last 20 years. Ideas such as early treatment, treat to target, sustained remission, treatment of comorbidities, diminishing toxicities, improving functioning, quality of life and life expectancy and the availability of new therapeutic options are melt together in clinicians mind and health care systems to improve RA treatment. How this is implemented in real life clinical practice is something that has not been properly evaluated.</p><p id="par0010" class="elsevierStylePara elsevierViewall">An original article by Machado-Alba in this number of the journal evaluates the time to and factors associated with initiation of biological therapy in patients with rheumatoid arthritis in Colombia.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> After a careful study of 3880 RA patients, 6% of them initiated a biologic therapy in a mean initiation time of 17.5 months. Some interesting findings arised. In a multivariate analysis, being male, have received glucocorticoid therapy or comedication, living in Bogota or in the Atlantic coast were associated with an increased risk of receiving a biologic therapy while the use of methotrexate, chloroquine or antihypertensive therapy were protective against the use of it.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Some important lessons have to be emphasized while reading and interpreting this article. We must note that RA treatment is a very dynamic process and therapeutic guidelines emphasize the importance of disease control and treatment of comorbidities.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> This paper does not have measures of disease activity to properly judge how adequate therapeutic decisions were made. This should be included in future studies.</p><p id="par0020" class="elsevierStylePara elsevierViewall">As a clinician, the number of 6% of RA patients who initiated a biologic treatment seems to be a low number that should raise possible explanations. This could be due to the year when the study was started, some access difficulties, some barriers in prescription, and other practical aspects.</p><p id="par0025" class="elsevierStylePara elsevierViewall">If male RA subjects have an increased risk of receiving a biologic therapy, gender inequity, disease activity, and work productivity pressure are some variables that have to considered. This is something that needs further evaluation.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The use of conventional synthetic disease modifying antirheumatic drugs such as methotrexate of chloroquine was useful to minimize the use of biologic therapy. A clear message to all rheumatologists who treat these patients in a region where resources are limited and should be optimized.</p><p id="par0035" class="elsevierStylePara elsevierViewall">This type of studies are clearly needed, not only to evaluate prescription practices but to better understand how we can improve RA treatment in our countries.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Time to and factors associated with initiation of biological therapy in patients with rheumatoid arthritis in Colombia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.E. Machado-Alba" 1 => "S. García-Betancur" 2 => "L.F. Calvo-Torres" 3 => "D.A. Medina-Morales" 4 => "A.M. Bañol-Giraldo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rcreu.2017.11.002-" "Revista" => array:2 [ "tituloSerie" => "Rev Colomb Reumatol" "fecha" => "2017" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.S. Smolen" 1 => "R. Landewé" 2 => "J. Bijlsma" 3 => "G. Burmester" 4 => "K. Chatzidionysiou" 5 => "M. Dougados" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/annrheumdis-2016-210715" "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2017" "volumen" => "76" "paginaInicial" => "960" "paginaFinal" => "977" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28264816" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rheumatoid arthritis in Latin America. Important challenges to be solved" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Burgos Vargas" 1 => "M.H. Cardiel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10067-015-3048-1" "Revista" => array:7 [ "tituloSerie" => "Clin Rheumatol" "fecha" => "2015" "volumen" => "34" "numero" => "Suppl. 1" "paginaInicial" => "S1" "paginaFinal" => "S3" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26255192" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/01218123/0000002500000001/v1_201803210433/S0121812318300094/v1_201803210433/en/main.assets" "Apartado" => array:4 [ "identificador" => "18309" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/01218123/0000002500000001/v1_201803210433/S0121812318300094/v1_201803210433/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0121812318300094?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 3 | 0 | 3 |
2024 September | 4 | 2 | 6 |
2024 August | 11 | 5 | 16 |
2024 July | 6 | 1 | 7 |
2024 June | 8 | 2 | 10 |
2024 May | 13 | 8 | 21 |
2024 April | 12 | 14 | 26 |
2024 March | 13 | 13 | 26 |
2024 February | 8 | 7 | 15 |
2024 January | 9 | 2 | 11 |
2023 December | 5 | 6 | 11 |
2023 November | 10 | 5 | 15 |
2023 October | 19 | 12 | 31 |
2023 September | 13 | 2 | 15 |
2023 August | 13 | 3 | 16 |
2023 July | 18 | 7 | 25 |
2023 June | 6 | 1 | 7 |
2023 May | 36 | 1 | 37 |
2023 April | 29 | 3 | 32 |
2023 March | 16 | 8 | 24 |
2023 February | 16 | 2 | 18 |
2023 January | 4 | 2 | 6 |
2022 December | 8 | 4 | 12 |
2022 November | 20 | 8 | 28 |
2022 October | 11 | 13 | 24 |
2022 September | 9 | 13 | 22 |
2022 August | 20 | 12 | 32 |
2022 July | 11 | 11 | 22 |
2022 June | 19 | 8 | 27 |
2022 May | 39 | 7 | 46 |
2022 April | 20 | 9 | 29 |
2022 March | 10 | 14 | 24 |
2022 February | 19 | 5 | 24 |
2022 January | 33 | 9 | 42 |
2021 December | 31 | 10 | 41 |
2021 November | 20 | 8 | 28 |
2021 October | 7 | 8 | 15 |
2021 September | 8 | 8 | 16 |
2021 August | 19 | 9 | 28 |
2021 July | 28 | 12 | 40 |
2021 June | 17 | 11 | 28 |
2021 May | 10 | 9 | 19 |
2021 April | 22 | 20 | 42 |
2021 March | 17 | 12 | 29 |
2021 February | 5 | 7 | 12 |
2021 January | 10 | 8 | 18 |
2020 December | 11 | 11 | 22 |
2020 November | 7 | 6 | 13 |
2020 October | 11 | 8 | 19 |
2020 September | 12 | 9 | 21 |
2020 August | 8 | 8 | 16 |
2020 July | 2 | 9 | 11 |
2020 June | 7 | 11 | 18 |
2020 May | 7 | 5 | 12 |
2020 April | 13 | 7 | 20 |
2020 March | 12 | 5 | 17 |
2020 February | 13 | 1 | 14 |
2020 January | 20 | 7 | 27 |
2019 December | 13 | 5 | 18 |
2019 November | 9 | 4 | 13 |
2019 October | 8 | 4 | 12 |
2019 September | 10 | 5 | 15 |
2019 August | 3 | 0 | 3 |
2019 July | 6 | 18 | 24 |
2019 June | 32 | 13 | 45 |
2019 May | 47 | 23 | 70 |
2019 April | 10 | 12 | 22 |
2019 March | 4 | 0 | 4 |
2019 February | 7 | 4 | 11 |
2019 January | 2 | 3 | 5 |
2018 December | 3 | 3 | 6 |
2018 November | 4 | 7 | 11 |
2018 October | 9 | 11 | 20 |
2018 September | 12 | 6 | 18 |
2018 August | 13 | 0 | 13 |
2018 July | 7 | 1 | 8 |
2018 June | 12 | 2 | 14 |
2018 May | 18 | 1 | 19 |
2018 April | 21 | 1 | 22 |
2018 March | 13 | 7 | 20 |